Incision: Funding, Investors & Team (Sep 2026)

Incision is a rapidly growing platform that aims to improve surgical performance and provide online training. Our main goal is to connect surgical professionals and help them reach their full potential. Our mobile app serves as a digital assistant for the surgical team, offering visual learning, preparation tools, and facilitating collaboration among team members. We strongly believe in sharing surgical skills and making high-quality knowledge accessible to everyone. This is why we created Incision, to promote continuous improvement in surgical practices and ultimately achieve better outcomes for all patients. We collaborate with renowned clinics, societies, and hospitals worldwide to provide accurate and top-notch content and services. Our focus on product leadership has earned us accreditations and endorsements from prestigious international institutes. We have a distinguished Shareholder Board and a Medical Advisory Board comprising renowned surgeons and medical entrepreneurs. Our mission is to constantly find new ways to support the surgical team and streamline their challenging tasks. Ultimately, our vision is to become the global digital assistant for surgical professionals and the leading technology in that field. By 2030, we aspire to impact 100 million procedures annually, connecting thousands of clinics and millions of surgical professionals worldwide.

Incision has raised $7.0M across 1 round on record. The most recent is a Series B of $7.0M announced in Nov 2023.

Incision's most recent funding round on record is a Series B of $7.0M, announced in Nov 2023.

Nicholas Desuza is listed as CEO at Incision.

Incision is based in Amsterdam, Noord-Holland, Netherlands.

Incision is in the 101-250 employee band.

Incision's latest round of $7.0M is above the $1.5M median round size for Education companies on FundedIQ across 1,474 tracked companies over the last two years.